Zhejiang Jingxin Pharmaceuticals (investor - Corporate Investor)
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a listed pharmaceutical company, integrating R & D, manufacturing and marketing, ranking among the top 100 of the chemical pharmaceutical enterprises in China with current registered capital of 320 million CNY and total assets of 2.9 billion CNY.
The company has 2300 staff, headquarters in both Xinchang and Hangzhou and five manufacturing sites.
Jingxin attaches great importance to R&D, besides having its own world-class infrastructure for R&D, the company also works closely with institutes and universities to reinforce the commitment to innovative products and is involved with 8 National Key New Products and 9 National Torch Plans.
In the medical device arm of the business, Jingxin currently focuses on medical display instruments, providing complete medical imaging display pathway solutions, covering all medical imaging application areas, including clinical review, diagnostic, consultation center, digitized surgical room and ultrasound, CT, MRI, DR, DSA, DSI, endoscope etc.
Jingxin’s strategy is to accelerate growth through both independent research and development and M&A. In the domestic market, Jingxin acquired a TCM factory in Inner Mongolia in 2007, a bio-medicine company in Beijing in 2011, a comprehensive pharmaceutical company in Guangdong Province in 2013 and an advanced medical devices company in 2015.
Internationally, Jingxin set up a joint venture in UK in 2014, invested in a medical device company in Israel in 2015 and took corporate control of a US pharmaceutical company in 2015.
1 tracked Nordic investments in:
|Name||Date||Round value||Total raised|
* The round values and totals raised are in USD.
** Click on the company for its details and on the round amount for the investment details.